Literature DB >> 32505176

Chromosome aberrations in pressure-induced triploid Atlantic salmon.

K A Glover1,2, A C Harvey3, T J Hansen1, P G Fjelldal1, F N Besnier1, J B Bos4, F Ayllon1, J B Taggart5, M F Solberg1.   

Abstract

BACKGROUND: Triploid organisms have three sets of chromosomes. In Atlantic salmon, hydrostatic pressure treatment of newly fertilized eggs has been extensively used to produce triploids which are functionally sterile due to their unpaired chromosomes. These fish often perform poorly on commercial farms, sometimes without explanation. Inheritance patterns in individuals subjected to pressure treatment have not been investigated in Atlantic salmon thus far. However, work on other species suggests that this treatment can result in aberrant inheritance. We therefore studied this in Atlantic salmon by genotyping 16 polymorphic microsatellites in eyed eggs and juveniles which had been subjected to pressure-induction of triploidy. Communally reared juveniles including fish subjected to pressure-induction of triploidy and their diploid siblings were included as a control.
RESULTS: No diploid offspring were detected in any of the eggs or juveniles which were subjected to hydrostatic pressure; therefore, the induction of triploidy was highly successful. Aberrant inheritance was nevertheless observed in 0.9% of the eggs and 0.9% of the juveniles that had been subjected to pressure treatment. In the communally reared fish, 0.3% of the fish subjected to pressure treatment displayed aberrant inheritance, while their diploid controls displayed 0% aberrant inheritance. Inheritance errors included two eyed eggs lacking maternal DNA across all microsatellites, and, examples in both eggs and juveniles of either the maternal or paternal allele lacking in one of the microsatellites. All individuals displaying chromosome aberrations were otherwise triploid.
CONCLUSIONS: This is the first study to document aberrant inheritance in Atlantic salmon that have been subjected to pressure-induction of triploidy. Our experiments unequivocally demonstrate that even when induction of triploidy is highly successful, this treatment can cause chromosome aberrations in this species. Based upon our novel data, and earlier studies in other organisms, we hypothesize that in batches of Atlantic salmon where low to modest triploid induction rates have been reported, aberrant inheritance is likely to be higher than the rates observed here. Therefore, we tentatively suggest that this could contribute to the unexplained poor performance of triploid salmon that is occasionally reported in commercial aquaculture. These hypotheses require further investigation.

Entities:  

Keywords:  Aneuploid; Aquaculture; Environmental impact; Mosaic; PUD; Triploid; Trisomy; Welfare

Year:  2020        PMID: 32505176     DOI: 10.1186/s12863-020-00864-0

Source DB:  PubMed          Journal:  BMC Genet        ISSN: 1471-2156            Impact factor:   2.797


  3 in total

1.  Morphological and molecular evolution of hadal amphipod's eggs provides insights into embryogenesis under high hydrostatic pressure.

Authors:  Wenhao Li; Faxiang Wang; Shouwen Jiang; Binbin Pan; Qi Liu; Qianghua Xu
Journal:  Front Cell Dev Biol       Date:  2022-09-12

2.  Autosomal sdY Pseudogenes Explain Discordances Between Phenotypic Sex and DNA Marker for Sex Identification in Atlantic Salmon.

Authors:  Fernando Ayllon; Monica Favnebøe Solberg; François Besnier; Per Gunnar Fjelldal; Tom Johnny Hansen; Anna Wargelius; Rolf Brudvik Edvardsen; Kevin Alan Glover
Journal:  Front Genet       Date:  2020-10-14       Impact factor: 4.599

3.  Effects of Hydrostatic Pressure Treatment of Newly Fertilized Eggs on the Ploidy Level and Karyotype of Pikeperch Sander lucioperca (Linnaeus, 1758).

Authors:  Jenő Káldy; Eszter Patakiné Várkonyi; Georgina Lea Fazekas; Zoltán Nagy; Zsuzsanna J Sándor; Katalin Bogár; Gyula Kovács; Mariann Molnár; Bence Lázár; Katalin Goda; Zsuzsanna Gyöngy; Zsuzsanna Ritter; Péter Nánási; Ákos Horváth; Uroš Ljubobratović
Journal:  Life (Basel)       Date:  2021-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.